-+ 0.00%
-+ 0.00%
-+ 0.00%

Zejing Pharmaceutical (688266.SH) re-submitted an H share listing application to the Hong Kong Stock Exchange and published the application materials

Zhitongcaijing·08/13/2026 08:33:30
Listen to the news

Zhitong Financial App News, Zejing Pharmaceutical (688266.SH) issued an announcement. On August 12, 2026, the company re-submitted an application to the Hong Kong Stock Exchange Limited (hereinafter referred to as “Hong Kong Stock Exchange”) to issue H shares and list them on the main board of the Hong Kong Stock Exchange, and published the application materials for this issuance and listing on the Hong Kong Stock Exchange website on the same day. The application materials are prepared and published by the company in accordance with the requirements of the Hong Kong Securities and Futures Commission (hereinafter referred to as the “Hong Kong Securities Regulatory Commission”) and the Hong Kong Stock Exchange. It is a draft version. The information contained in it may be updated and revised in due course, and investors should not make any investment decisions based on the information contained in it.